|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4689 | Drugs / Medical | 03/06/2006
A class action lawsuit was filed in federal court in Baton Rouge that claims a New York medical supply company sold illegal tissue and bone to Baton Rouge hospital Our Lady of the Lake Regional Medical Center and other unnamed hospitals in Louisiana. Darrel Bourque says surgeons notified him in January that tissue transplanted in his neck during spinal surgery a year ago came from Biomedical Tissue Services.
Biomedical urged Bourque to undergo blood testing to see if the transplanted tissue was infected with syphilis, H-I-V or hepatitis. In an advisory issued by the U.S. Food and Drug Administration, the FDA "strongly" recommended health care providers to inform patients who received tissue implants from Biomedical Tissue Services that they "may be at increased risk for communicable disease transmission and to offer them testing. While FDA believes the risks from these tissues are low the actual infectious risk is unknown." The lawsuit estimates the defective tissue has been implanted in hundreds of Louisiana patients since 2002. Besides damages, it seeks to establish a comprehensive medical monitoring program and treatment of any future disease or complication related to the implants. Biomedical Tissue Services owners Michael Mastromarino and Joseph Nicelli and others are accused of secretly carving up bodies from funeral parlors and city morgues in three states and forging death certificates and organ-donor consent forms to make it appear as if the bones, skin, tendons, heart valves and other tissues were removed legally. Some of the corpses were those of people who had not given consent; others didn't meet federal donor eligibility requirements because they were infected with syphilis, AIDS or hepatitis or had cancer or heart disease. Register your Biomedical Tissue Services ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Biomedical Tissue Services, or click the red "submit" button on this page, and a lawyer will review your Biomedical Tissue Services complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Kahn Gauthier Swick is investigating possible legal actions against drug giant Pfizer, Inc., the manufacturer of the prescription drug Neurontin (gabapentin), to recover for harm suffered by patients who have been prescribed Neurontin. Several class actions have been filed against medical information technology systems company IMPAC Medical Systems, Inc. (Nasdaq:IMPCE), and certain of its officers and directors by stockholders who purchased the company's common stock between November 20, 2002, and May 13, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. Numerous class actions have been filed against nonprofit hospitals in Illinois, Minnesota, Ohio, Texas, Georgia, Alabama, Florida and Tennessee, on behalf of uninsured patients who allege that the hospitals do not honor their promise of charity care as defined in their tax-exempt status. The suits claim that the hospitals are charging uninsured patients "sticker" price while insurance companies negotiate large discounts for the same services provided to those with medical coverage, violating the hospitals’ tax-exempt status. Several class actions have been filed against online pharmacy drugstore.com, Inc., (Nasdaq:DSCM) and certain of its officers and directors by stockholders who purchased the company's common stock between January 20, 2004, and June 10, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The parties have reached a $750,000 settlement in an FTC administrative proceeding filed against dietary supplement marketer VisionTel Communications, LLC, on behalf of all persons who purchased Chito-Trim or TurboTone for weight loss, or Impulse Female Herbal Blend/ Maximus Male Herbal Blend for male and female sexual dysfunction. The action alleged that the marketers made deceptive advertising claims about these products in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information. Several class actions have been filed against hospice operator Odyssey Healthcare, Inc. (Nasdaq:ODSY) and certain of its officers and directors by stockholders who purchased the company's common stock between May 5, 2003, and February 23, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
